FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:467-468 February 11, 1999 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Hébert, P. C. Related Article by Goodnough, L. T. PubMed Citation

The art of fluid administration and hemodynamic support is one of the most challenging aspects of treating critically ill patients. Considering that every year in the United States over 11 million units of red cells are transfused in more than 3 million patients,¹ there is a surprising paucity of data to guide decisions about transfusions. The American College of Physicians has a prudent transfusion algorithm,² but it is based mainly on a consensus of experts, not on data from controlled clinical trials. The use of transfusions in critically ill patients varies widely, with hemoglobin thresholds ranging from 7 to 12 . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Wu, W.-C., Rathore, S. S., Wang, Y., Radford, M. J., Krumholz, H. M. (2001). Blood Transfusion in Elderly Patients with Acute Myocardial Infarction. NEJM 345: 1230-1236 [Abstract] [Full Text]  
• Vamvakas, E. C., Blajchman, M. A. (2001). Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?. Blood 97: 1180-1195 [Full Text]